Make Informed Investment Decisions with Affordable Access to Experts

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Examining the market size and potential of Endo's collagenase clostridium histolyticum (XIAFLEX) if approved to treat cellulite

Ticker(s): ENDP

Who's the expert?

Institution: Plastic Surgery Institute of New York

  • Triple board certified plastic surgeon (Plastic Surgery, Reconstructive Surgery, Otolaryngology) who specializes in aesthetic procedures of the face, breast and body.
  • Performs 10 Silhouette InstaLift procedures per month.
  • Published in numerous peer-reviewed journals and textbooks on plastic surgery. 

Interview Questions
Q1.

Please describe your practice and types of patients you see daily?

Added By: c_admin
Q2.

What are your initial thoughts on the Phase 2b Study of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite?

Added By: c_admin
Q3.

If approved in the cellulite indication, how likely would you be to treat your patients with Xiaflex?

Added By: c_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.